cephalosporin c has been researched along with isoxazoles in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, SP; Ikeda, D; Kondo, S; Koyama, Y; Takeuchi, T | 3 |
Albini, E; Carenzi, A; Chiarino, D; Della Bella, D; Napoletano, M; Sala, A | 1 |
Hussar, DA | 1 |
Chang, M; Choi, H; Choi, S; Lang, J; Park, H; Rhee, J | 1 |
6 other study(ies) available for cephalosporin c and isoxazoles
Article | Year |
---|---|
Synthesis and activity of 3-(isoxazolin-5-yl)- and 3-(isoxazol-4-yl)cephalosporins.
Topics: Anti-Bacterial Agents; Cephalosporins; Gas Chromatography-Mass Spectrometry; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoxazoles; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests | 1992 |
Synthesis and activity of potent 3-(isoxazolidin-5-yl)- and 3-(isoxazolidinium-5-yl)cephalosporins.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Isomerism; Isoxazoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 1992 |
Orally active pivaloyloxymethyl 3-(isoxazolidin-5-yl)cephalosporins.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cephalosporins; Intestinal Absorption; Isoxazoles; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1992 |
Synthesis and antibacterial properties of 7-[2-(3-substituted-5-isoxazolyl)-2-methoxyiminoacetamido]cep halospora nic acid derivatives.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Cephalosporins; Isomerism; Isoxazoles; Microbial Sensitivity Tests; Oxazoles; Rats; Structure-Activity Relationship | 1987 |
New drugs 99, Part IV.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Cefdinir; Cephalosporins; Citalopram; Drug Therapy; Etanercept; Humans; Immunoglobulin G; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Serotonin Receptor Agonists; Telmisartan; Tetrazoles; Triazoles; Tryptamines; United States; United States Food and Drug Administration | 1999 |
Synthesis and in vitro antibacterial activity of cephalosporins with a pyridinium substituent carrying an isoxazole moiety at the C-3 position.
Topics: Cephalosporins; Isoxazoles; Microbial Sensitivity Tests; Pseudomonas; Pyridinium Compounds; Staphylococcus; Structure-Activity Relationship | 2001 |